122 related articles for article (PubMed ID: 16221611)
1. Characterization and body distribution of beta-elemene solid lipid nanoparticles (SLN).
Wang Y; Deng Y; Mao S; Jin S; Wang J; Bi D
Drug Dev Ind Pharm; 2005 Sep; 31(8):769-78. PubMed ID: 16221611
[TBL] [Abstract][Full Text] [Related]
2. [The pharmacokinetics of long-circulating beta-elemene liposomes].
Zhang BJ; Li WC; Liu XP
Zhong Yao Cai; 2012 Sep; 35(9):1464-8. PubMed ID: 23451504
[TBL] [Abstract][Full Text] [Related]
3. Preparation, characterization and relative bioavailability of oral elemene o/w microemulsion.
Zeng Z; Zhou G; Wang X; Huang EZ; Zhan X; Liu J; Wang S; Wang A; Li H; Pei X; Xie T
Int J Nanomedicine; 2010 Sep; 5():567-72. PubMed ID: 20856831
[TBL] [Abstract][Full Text] [Related]
4. Formulation design, preparation, and in vitro and in vivo characterizations of β-Elemene-loaded nanostructured lipid carriers.
Shi F; Yang G; Ren J; Guo T; Du Y; Feng N
Int J Nanomedicine; 2013; 8():2533-41. PubMed ID: 23901271
[TBL] [Abstract][Full Text] [Related]
5. The Preparation, Determination of a Flexible Complex Liposome Co-Loaded with Cabazitaxel and β-Elemene, and Animal Pharmacodynamics on Paclitaxel-Resistant Lung Adenocarcinoma.
Zeng YY; Zeng YJ; Zhang NN; Li CX; Xie T; Zeng ZW
Molecules; 2019 Apr; 24(9):. PubMed ID: 31052317
[TBL] [Abstract][Full Text] [Related]
6. Preparation, characterization, pharmacokinetics and anticancer effects of PEGylated β-elemene liposomes.
Zhai B; Wu Q; Wang W; Zhang M; Han X; Li Q; Chen P; Chen X; Huang X; Li G; Zhang Q; Zhang R; Xiang Y; Liu S; Duan T; Lou J; Xie T; Sui X
Cancer Biol Med; 2020 Feb; 17(1):60-75. PubMed ID: 32296587
[No Abstract] [Full Text] [Related]
7. In vitro evaluation of idebenone-loaded solid lipid nanoparticles for drug delivery to the brain.
Montenegro L; Campisi A; Sarpietro MG; Carbone C; Acquaviva R; Raciti G; Puglisi G
Drug Dev Ind Pharm; 2011 Jun; 37(6):737-46. PubMed ID: 21204752
[TBL] [Abstract][Full Text] [Related]
8. Preparation, characterization and in vivo distribution of solid lipid nanoparticles loaded with cisplatin.
Tian J; Pang X; Yu K; Liu L; Zhou J
Pharmazie; 2008 Aug; 63(8):593-7. PubMed ID: 18771008
[TBL] [Abstract][Full Text] [Related]
9. Solid lipid nanoparticles of mitoxantrone for local injection against breast cancer and its lymph node metastases.
Lu B; Xiong SB; Yang H; Yin XD; Chao RB
Eur J Pharm Sci; 2006 May; 28(1-2):86-95. PubMed ID: 16472996
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics of doxorubicin incorporated in solid lipid nanospheres (SLN).
Zara GP; Cavalli R; Fundarò A; Bargoni A; Caputo O; Gasco MR
Pharmacol Res; 1999 Sep; 40(3):281-6. PubMed ID: 10479474
[TBL] [Abstract][Full Text] [Related]
11. Drug delivery systems for elemene, its main active ingredient β-elemene, and its derivatives in cancer therapy.
Zhai B; Zeng Y; Zeng Z; Zhang N; Li C; Zeng Y; You Y; Wang S; Chen X; Sui X; Xie T
Int J Nanomedicine; 2018; 13():6279-6296. PubMed ID: 30349250
[TBL] [Abstract][Full Text] [Related]
12. Preparation and characterization of solid lipid nanoparticles containing peptide.
Hu FQ; Hong Y; Yuan H
Int J Pharm; 2004 Apr; 273(1-2):29-35. PubMed ID: 15010127
[TBL] [Abstract][Full Text] [Related]
13. Non-stealth and stealth solid lipid nanoparticles (SLN) carrying doxorubicin: pharmacokinetics and tissue distribution after i.v. administration to rats.
Fundarò A; Cavalli R; Bargoni A; Vighetto D; Zara GP; Gasco MR
Pharmacol Res; 2000 Oct; 42(4):337-43. PubMed ID: 10987994
[TBL] [Abstract][Full Text] [Related]
14. In vivo pharmacokinetics and biodistribution of resveratrol-loaded solid lipid nanoparticles for brain delivery.
Jose S; Anju SS; Cinu TA; Aleykutty NA; Thomas S; Souto EB
Int J Pharm; 2014 Oct; 474(1-2):6-13. PubMed ID: 25102112
[TBL] [Abstract][Full Text] [Related]
15. Development of β-elemene and Cisplatin Co-Loaded Liposomes for Effective Lung Cancer Therapy and Evaluation in Patient-Derived Tumor Xenografts.
Cao M; Long M; Chen Q; Lu Y; Luo Q; Zhao Y; Lu A; Ge C; Zhu L; Chen Z
Pharm Res; 2019 Jun; 36(8):121. PubMed ID: 31214786
[TBL] [Abstract][Full Text] [Related]
16. Self-reporter shikonin-Act-loaded solid lipid nanoparticle: formulation, physicochemical characterization and geno/cytotoxicity evaluation.
Eskandani M; Nazemiyeh H
Eur J Pharm Sci; 2014 Aug; 59():49-57. PubMed ID: 24768857
[TBL] [Abstract][Full Text] [Related]
17. Topical Amphotericin B solid lipid nanoparticles: Design and development.
Butani D; Yewale C; Misra A
Colloids Surf B Biointerfaces; 2016 Mar; 139():17-24. PubMed ID: 26700229
[TBL] [Abstract][Full Text] [Related]
18. Histopathological evaluation of caffeine-loaded solid lipid nanoparticles in efficient treatment of cellulite.
Hamishehkar H; Shokri J; Fallahi S; Jahangiri A; Ghanbarzadeh S; Kouhsoltani M
Drug Dev Ind Pharm; 2015; 41(10):1640-6. PubMed ID: 25382163
[TBL] [Abstract][Full Text] [Related]
19. The effect of a lipid composition and a surfactant on the characteristics of the solid lipid microspheres and nanospheres (SLM and SLN).
Sznitowska M; Wolska E; Baranska H; Cal K; Pietkiewicz J
Eur J Pharm Biopharm; 2017 Jan; 110():24-30. PubMed ID: 27815177
[TBL] [Abstract][Full Text] [Related]
20. Preparation and characterization of β-elemene-loaded microemulsion.
Hu CJ; Zhao XL; Li JZ; Kang SM; Yang CR; Jin YH; Liu D; Chen DW
Drug Dev Ind Pharm; 2011 Jul; 37(7):765-74. PubMed ID: 21244276
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]